Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 10633
TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555817(US11345679, Example 23 | Preparation of Compound I...)
Affinity DataIC50: 1.5nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555822(US11345679, Example 55 | Preparation of Compound I...)
Affinity DataIC50: 1.70nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555813(US11345679, Example 16 | Preparation of Compound I...)
Affinity DataIC50: 1.89nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555822(US11345679, Example 55 | Preparation of Compound I...)
Affinity DataIC50: 2.40nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555823(US11345679, Example 31 | Preparation of Compound I...)
Affinity DataIC50: 2.80nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555819(US11345679, Example 25 | Preparation of Compound I...)
Affinity DataIC50: 3.20nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555831(US11345679, Example 51 | Preparation of Compound I...)
Affinity DataIC50: 3.30nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555825(US11345679, Example 33 | Preparation of Compound I...)
Affinity DataIC50: 3.5nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555818(US11345679, Example 24 | Preparation of Compound I...)
Affinity DataIC50: 3.60nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555828(US11345679, Example 44 | Preparation of Compound I...)
Affinity DataIC50: 3.80nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555824(US11345679, Example 32 | Preparation of Compound I...)
Affinity DataIC50: 4.10nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555826(US11345679, Example 41 | Preparation of Compound I...)
Affinity DataIC50: 4.10nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555829(US11345679, Example 45 | Preparation of Compound I...)
Affinity DataIC50: 5.30nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555815(US11345679, Example 19 | Preparation of Compound I...)
Affinity DataIC50: 5.99nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555830(US11345679, Example 46 | Preparation of Compound I...)
Affinity DataIC50: 7.70nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555827(US11345679, Example 42 | Preparation of Compound I...)
Affinity DataIC50: 9.10nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555814(US11345679, Example 18 | Preparation of Compound I...)
Affinity DataIC50: 10.7nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555816(US11345679, Example 20 | Preparation of Compound I...)
Affinity DataIC50: 10.8nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555820(US11345679, Example 26 | Preparation of Compound I...)
Affinity DataIC50: 11.1nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555821(US11345679, Example 28 | Preparation of Compound I...)
Affinity DataIC50: 23.1nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Shanghai Meiyue Biotech Development

US Patent
LigandPNGBDBM555812(US11345679, Example 13 | Preparation of Compound I...)
Affinity DataIC50: 23.2nMAssay Description:Method: the test compound was dissolved in 10 mM mother liquor with DMSO, and stored at −80° C. until use. The frozen mother liquor was diluted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent